Silencing Bmi-1 expression by RNA interference suppresses the growth of laryngeal carcinoma cells

Yao,Xiao-Bao; Wang,Xiao-Xia; Liu,Hui; Zhang,Shao-Qiang; Zhu,Hong-Liang

doi:10.3892/ijmm.2013.1312

Silencing Bmi-1 expression by RNA interference suppresses the growth of laryngeal carcinoma cells

Authors:
- Xiao-Bao Yao
- Xiao-Xia Wang
- Hui Liu
- Shao-Qiang Zhang
- Hong-Liang Zhu
View Affiliations

Affiliations: Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Otolaryngology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China
Published online on: March 20, 2013 https://doi.org/10.3892/ijmm.2013.1312
Pages: 1262-1272

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the effect of a B-cell-specific MLV integration site-1 (Bmi-1) RNA interference (RNAi) expression vector on the proliferation and invasiveness of laryngeal carcinoma. We constructed a lentiviral vector expressing Bmi-1-specific short hairpin RNA (shRNA), and transfected it into HEp-2 cells. Bmi-1 gene expression was detected by real-time RT-PCR and western blot analysis. We used flow cytometry and TUNEL assay to analyze the apoptosis of transfected cells, and examined cellular growth in vitro by MTT assay. We established an animal model and evaluated the therapeutic effects of small interfering RNA (siRNA) against Bmi-1. siRNA against Bmi-1 significantly knocked down Bmi-1 expression in HEp-2 cells, induced cell cycle arrest at the G1 phase, inhibited cell proliferation and promoted cell apoptosis. Lentiviral Bmi-1-shRNA vector transfection also significantly reduced cell migration. The formation and growth rate of xenograft tumors in mice transfected with siRNA against Bmi-1 was significantly reduced. The loss of mitochondrial membrane potential, the release of cytochrome c from the mitochondria into the cytosol, and the increased activity of caspase-3, -8 and -9 occurred concomitantly with the inhibition of Bmi-1. Our data indicate that siRNA against Bmi-1 significantly suppresses tumor growth and induces apoptosis in vitro and in vivo.

View Figures

View References

1	Marioni G, Marchese-Ragona R, Cartei G, Marchese F and Staffieri A: Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat Rev. 32:504–515. 2006. View Article : Google Scholar : PubMed/NCBI
2	Papadas TA, Alexopoulos EC, Mallis A, Jelastopulu E, Mastronikolis NS and Goumas P: Survival after laryngectomy: a review of 133 patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol. 267:1095–1101. 2010. View Article : Google Scholar : PubMed/NCBI
3	Sun YN, Liu M, Yang B, Li B and Lu J: Role of siRNA silencing of MMP-2 gene on invasion and growth of laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 265:1385–1391. 2008. View Article : Google Scholar : PubMed/NCBI
4	Zhao JX and Xie XL: Regulation of gene expression in laryngeal carcinama by microRNAs. Int J Pathol Clin Med. 32:222–225. 2012.
5	Srivastava R: Apoptosis, Cell Signaling, and Human Diseases Molecular Mechanisms. 1. Humana Press; Totowa: 2007
6	Bea S, Tort F, Pinyol M, et al: BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res. 61:2409–2412. 2001.
7	Bhattacharyya J, Mihara K, Ohtsubo M, et al: Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression. Cancer Sci. 103:34–41. 2012. View Article : Google Scholar : PubMed/NCBI
8	Sawa M, Yamamoto K, Yokozawa T, et al: BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int J Hematol. 82:42–47. 2005. View Article : Google Scholar : PubMed/NCBI
9	Kimura M, Takenobu H, Akita N, et al: Bmi1 regulates cell fate via tumor suppressor WWOX repression in small-cell lung cancer cells. Cancer Sci. 102:983–990. 2011. View Article : Google Scholar : PubMed/NCBI
10	Kim JH, Yoon SY, Kim CN, et al: The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett. 203:217–224. 2004. View Article : Google Scholar : PubMed/NCBI
11	Glinsky GV, Berezovska O and Glinskii AB: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest. 115:1503–1521. 2005. View Article : Google Scholar : PubMed/NCBI
12	Song W, Tao K, Li H, et al: Bmi1 is related to proliferation, survival and poor prognosis in pancreatic cancer. Cancer Sci. 101:1754–1760. 2010. View Article : Google Scholar : PubMed/NCBI
13	Yao X, Wang X, Zhang S and Zhu H: Effects of Bmi-1 RNAi gene on laryngeal carcinoma Hep-2 cells. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 26:550–557. 2012.(In Chinese).
14	Kang MK, Kim RH, Kim SJ, et al: Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer. 96:126–133. 2007. View Article : Google Scholar : PubMed/NCBI
15	Song LB, Zeng MS, Liao WT, et al: Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res. 66:6225–6232. 2006. View Article : Google Scholar
16	Glinsky GV: Death-from-cancer signatures and stem cell contribution to metastatic cancer. Cell Cycle. 4:1171–1175. 2005. View Article : Google Scholar : PubMed/NCBI
17	Hoenerhoff MJ, Chu I, Barkan D, et al: BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. Oncogene. 28:3022–3032. 2009. View Article : Google Scholar : PubMed/NCBI
18	Xu CR, Lee SS, Ho C, et al: Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis. Mol Cancer Res. 7:1937–1945. 2009. View Article : Google Scholar : PubMed/NCBI
19	Elbashir SM, Harborth J, Lendeckel W, et al: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494–498. 2011. View Article : Google Scholar : PubMed/NCBI
20	Mittal V: Improving the efficiency of RNA interference in mammals. Nat Rev Genet. 5:355–365. 2004. View Article : Google Scholar : PubMed/NCBI
21	Moffat J and Sabatini DM: Building mammalian signalling pathways with RNAi screens. Nat Rev Mol Cell Biol. 7:177–187. 2006. View Article : Google Scholar : PubMed/NCBI
22	Kim DH and Rossi JJ: Strategies for silencing human diseaseusing RNA interference. Nat Rev Genet. 8:173–184. 2007. View Article : Google Scholar : PubMed/NCBI
23	Huang XZ and Wang JB: Practical otolaryngology. People’s Medical Publishing House; Beijing: pp. 502–503. 1998
24	Tu Gy, Tang PZ and Jia CY: Horizontovertical laryngectomy for supraglottic carcinoma. Otolaryngol Head Neck Surg. 117:280–286. 1997. View Article : Google Scholar : PubMed/NCBI
25	Sessions DG, Lenox J, Spector GJ, et al: Management of T3N0M0 glottic carcinoma: therapeutic outcomes. Laryngoscope. 112:1281–1288. 2002. View Article : Google Scholar : PubMed/NCBI
26	Liu YZ, Tang PZ, Qi YF and Xu Z: The management of stomal recurrence after laryngectomy. Zhonghua Er Bi Yan Hou Ke Za Zhi. 37:380–383. 2002.(In Chinese).
27	Ringrose L and Paro R: Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet. 38:413–443. 2004. View Article : Google Scholar : PubMed/NCBI
28	Raaphorst FM: Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors. Hum Mol Genet. 14:R93–R100. 2005. View Article : Google Scholar : PubMed/NCBI
29	Kikuchi J, Kinoshita I, Shimizu Y, et al: Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance. Cancer. 116:3015–3024. 2010. View Article : Google Scholar
30	Yao XB, Wang XX, Zhang SQ, Yan LY and Zhu HL: Association of Bmi-1 mRNA overexpression with differentiation, metastasis and prognosis of laryngocarcinoma. Xi’An Jiaotong Daxue Xuebao. 32:246–249. 2011.(In Chinese).
31	Wang YX, Wei YM, Wang XH and Zhu XY: Construction of eukaryotic expression vector targeting Bmi-1 and its influences on proliferation of SW480 cells. Xian Dai Sheng Wu Yi Xue Jin Zhan. 9:2270–2272. 2009.(In Chinese).
32	Wang ZX, Lu BB, Yang JS, Wang KM and De W: Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells. J Surg Res. 171:127–135. 2011. View Article : Google Scholar : PubMed/NCBI
33	Li PH, Wang HJ, Liu W and Xu XG: PRDM1 gene expression in laryngeal carcinoma and its clinical significance. Head Neck Surg. 24:179–180. 2010.
34	Pirrotta V: Polycombing the genome: PcG, trxG, and chromatin silencing. Cell. 93:333–336. 1998. View Article : Google Scholar : PubMed/NCBI
35	Orlando V: Polycomb, epigenomes, and control of cell identity. Cell. 112:599–606. 2003. View Article : Google Scholar : PubMed/NCBI
36	Jacobs JJ, Kieboom K, Marino S, Depinho RA and van Lohuizen M: The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 397:164–168. 1999. View Article : Google Scholar : PubMed/NCBI
37	Itahana K, Zou Y, Itahana Y, et al: Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol. 23:389–401. 2003. View Article : Google Scholar : PubMed/NCBI
38	Dimri GP: What has senescence got to do with cancer? Cancer Cell. 7:505–512. 2005. View Article : Google Scholar : PubMed/NCBI
39	Xu Z, Liu H, Lv X, Liu Y, Li S and Li H: Knockdown of the Bmi-1 oncogene inhibits cell proliferation and induces cell apoptosis and is involved in the decrease of Akt phosphorylation in the human breast carcinoma cell line MCF-7. Oncol Rep. 25:409–418. 2011.PubMed/NCBI
40	Liu WL, Guo XZ, Zhang LJ, et al: Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma. BMC Cancer. 10:4672010. View Article : Google Scholar : PubMed/NCBI
41	Abdouh M, Facchino S, Chatoo W, et al: BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci. 29:8884–8896. 2009. View Article : Google Scholar : PubMed/NCBI